Literature DB >> 8293957

Inhibition of coaggregation between Porphyromonas gingivalis and Streptococcus oralis by fibrinogen fragments.

H Nagata1, A Amano, T Hanioka, H Tamagawa, S Shizukuishi, T Miyata.   

Abstract

The localization of regions of fibrinogen that inhibit coaggregation between Porphyromonas gingivalis and Streptococcus oralis was investigated. The coaggregation was inhibited by A alpha and gamma chains, but not by B beta chain. The inhibitory activity of fragment D was more potent than that of fragment E. Some cyanogen bromide-treated fragments isolated from A alpha and gamma chains including the NH2-terminal 148-207 amino acid residues of A alpha chain (A alpha 148-207) and gamma 1-78 showed inhibitory activities. A alpha 148-207 was further digested with lysyl endopeptidase. A alpha 158-176 and A alpha 192-206 which contained four and two arginine residues, respectively, retained the inhibitory activities. When the arginine residues of these two peptides were modified by phenylglyoxal, the inhibitory activities were much reduced. These findings suggest that the arginine residues of some specific regions of fibrinogen may play an important role in the inhibition of the coaggregation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8293957     DOI: 10.1111/j.1574-6968.1993.tb06546.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  2 in total

1.  Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components.

Authors:  A Amano; S Shizukuishi; H Horie; S Kimura; I Morisaki; S Hamada
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus oralis functions as a coadhesin for Porphyromonas gingivalis major fimbriae.

Authors:  Kazuhiko Maeda; Hideki Nagata; Yumiko Yamamoto; Muneo Tanaka; Junko Tanaka; Naoto Minamino; Satoshi Shizukuishi
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.